Compare SGI & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGI | MEDP |
|---|---|---|
| Founded | 1846 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 13.4B |
| IPO Year | N/A | 2016 |
| Metric | SGI | MEDP |
|---|---|---|
| Price | $91.62 | $543.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 12 |
| Target Price | $93.67 | ★ $465.18 |
| AVG Volume (30 Days) | ★ 2.2M | 277.0K |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | N/A | ★ 25.36 |
| EPS | 1.58 | ★ 14.32 |
| Revenue | ★ $6,816,000,000.00 | $2,358,373,000.00 |
| Revenue This Year | $54.31 | $21.48 |
| Revenue Next Year | $6.43 | $11.90 |
| P/E Ratio | $58.22 | ★ $38.28 |
| Revenue Growth | ★ 39.29 | 13.88 |
| 52 Week Low | $53.10 | $250.05 |
| 52 Week High | $94.42 | $626.26 |
| Indicator | SGI | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 60.19 | 36.48 |
| Support Level | $89.84 | $530.96 |
| Resistance Level | $94.42 | $626.26 |
| Average True Range (ATR) | 2.67 | 18.24 |
| MACD | 0.23 | -8.14 |
| Stochastic Oscillator | 76.30 | 17.60 |
Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses, Tempur Sealy, Mattress Firm and Dreams. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.